Clinicians now have added ability to personalise care with the integration of two continuous monitoring solutions from Medtronic – Microstream capnography (CO2) and INVOS regional oximetry (rSO2) technology for perioperative and ICU care on the GE Healthcare CARESCAPE precision monitoring platform.
Shutterstock
Abstract polygonal handshake on dark background. Teamwork concept. 3D Rendering
FDA clearance and CE mark approval of the integration of these technologies on the CARESCAPE platform completes the full suite of Medtronic patient monitoring technologies available on the system. The combined solution also features GE Healthcare FlexAcuity which gives clinicians around the world the ability to choose care options based on patient acuity needs and assist them in their goal of earlier detection of patient deterioration.
Frank Chan, president of the Patient Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic, said: “Medtronic and GE Healthcare are both committed to expanding access to patient care around the world. This collaboration brings together our combined medical technology leadership to improve workflow, allowing clinicians more time to focus on what matters most – the patient. Together, we are empowering clinicians with actionable insights to personalise care.”
The INVOS regional oximetry (rSO2) technology solution monitors for signs of hemodynamic changes and deteriorating patient conditions associated with cerebral desaturation events. When used as an indication of compromised cerebral oxygenation, INVOS technology can help clinicians return the patient’s rSO2 to baseline and has been shown to improve postoperative outcomes including hospital length of stay, POD, and MOMM. Patients undergoing on-pump coronary artery bypass grafting (CABG) spent an average of 14 hours less in the ICU when receiving near-infrared spectroscopy-guided care with INVOS rSO2.
The advanced Microstream capnography (CO2) technology solution offers clinicians early indication of patient decline and is validated for neonate to adult patients. It uses a proprietary CO2-specific infrared wavelength that is highly accurate and unaffected by the presence of other gases. The technology also features Smart Capnography algorithms engineered to enhance patient safety, improve clinical workflow, and ease alarm fatigue by reducing clinically insignificant nuisance alarms by 53%. This technology potentially cuts down on the high demand placed on providers to respond to non-emergent issues.
